Search: (WFRF:(Barrett J)) pers:(Barrett John)
> (2014) >
Hematopoietic stem-...
-
Ustun, Celalettin
(author)
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis
- Article/chapterEnglish2014
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-245271
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-245271URI
-
https://doi.org/10.1200/JCO.2014.55.2018DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:129885760URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
PURPOSE: Advanced systemic mastocytosis (SM), a fatal hematopoietic malignancy characterized by drug resistance, has no standard therapy. The effectiveness of allogeneic hematopoietic stem-cell transplantation (alloHCT) in SM remains unknown.PATIENTS AND METHODS: In a global effort to define the value of HCT in SM, 57 patients with the following subtypes of SM were evaluated: SM associated with clonal hematologic non-mast cell disorders (SM-AHNMD; n = 38), mast cell leukemia (MCL; n = 12), and aggressive SM (ASM; n = 7). Median age of patients was 46 years (range, 11 to 67 years). Donors were HLA-identical (n = 34), unrelated (n = 17), umbilical cord blood (n = 2), HLA-haploidentical (n = 1), or unknown (n = 3). Thirty-six patients received myeloablative conditioning (MAC), and 21 patients received reduced-intensity conditioning (RIC).RESULTS: Responses in SM were observed in 40 patients (70%), with complete remission in 16 patients (28%). Twelve patients (21%) had stable disease, and five patients (9%) had primary refractory disease. Overall survival (OS) at 3 years was 57% for all patients, 74% for patients with SM-AHNMD, 43% for those with ASM, and 17% for those with MCL. The strongest risk factor for poor OS was MCL. Survival was also lower in patients receiving RIC compared with MAC and in patients having progression compared with patients having stable disease or response.CONCLUSION: AlloHCT was associated with long-term survival in patients with advanced SM. Although alloHCT may be considered as a viable and potentially curative therapeutic option for advanced SM in the meantime, given that this is a retrospective analysis with no control group, the definitive role of alloHCT will need to be determined by a prospective trial.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Reiter, Andreas
(author)
-
Scott, Bart L
(author)
-
Nakamura, Ryotaro
(author)
-
Damaj, Gandhi
(author)
-
Kreil, Sebastian
(author)
-
Shanley, Ryan
(author)
-
Hogan, William J
(author)
-
Perales, Miguel-Angel
(author)
-
Shore, Tsiporah
(author)
-
Baurmann, Herrad
(author)
-
Stuart, Robert
(author)
-
Gruhn, Bernd
(author)
-
Doubek, Michael
(author)
-
Hsu, Jack W
(author)
-
Tholouli, Eleni
(author)
-
Gromke, Tanja
(author)
-
Godley, Lucy A
(author)
-
Pagano, Livio
(author)
-
Gilman, Andrew
(author)
-
Wagner, Eva Maria
(author)
-
Shwayder, Tor
(author)
-
Bornhäuser, Martin
(author)
-
Papadopoulos, Esperanza B
(author)
-
Böhm, Alexandra
(author)
-
Vercellotti, Gregory
(author)
-
Van Lint, Maria Teresa
(author)
-
Schmid, Christoph
(author)
-
Rabitsch, Werner
(author)
-
Pullarkat, Vinod
(author)
-
Legrand, Faezeh
(author)
-
Yakoub-Agha, Ibrahim
(author)
-
Saber, Wael
(author)
-
Barrett, John
(author)
-
Hermine, Olivier
(author)
-
Hägglund, HansKarolinska Institutet,Uppsala universitet,Hematologi,Karolinska University Hospital, Stockholm, Sweden(Swepub:uu)hanha689
(author)
-
Sperr, Wolfgang R
(author)
-
Popat, Uday
(author)
-
Alyea, Edwin P
(author)
-
Devine, Steven
(author)
-
Deeg, H Joachim
(author)
-
Weisdorf, Daniel
(author)
-
Akin, Cem
(author)
-
Valent, Peter
(author)
-
Uppsala universitetHematologi
(creator_code:org_t)
Related titles
-
In:Journal of Clinical Oncology32:29, s. 3264-32740732-183X1527-7755
Internet link
Find in a library
To the university's database
- By the author/editor
-
Ustun, Celaletti ...
-
Reiter, Andreas
-
Scott, Bart L
-
Nakamura, Ryotar ...
-
Damaj, Gandhi
-
Kreil, Sebastian
-
show more...
-
Shanley, Ryan
-
Hogan, William J
-
Perales, Miguel- ...
-
Shore, Tsiporah
-
Baurmann, Herrad
-
Stuart, Robert
-
Gruhn, Bernd
-
Doubek, Michael
-
Hsu, Jack W
-
Tholouli, Eleni
-
Gromke, Tanja
-
Godley, Lucy A
-
Pagano, Livio
-
Gilman, Andrew
-
Wagner, Eva Mari ...
-
Shwayder, Tor
-
Bornhäuser, Mart ...
-
Papadopoulos, Es ...
-
Böhm, Alexandra
-
Vercellotti, Gre ...
-
Van Lint, Maria ...
-
Schmid, Christop ...
-
Rabitsch, Werner
-
Pullarkat, Vinod
-
Legrand, Faezeh
-
Yakoub-Agha, Ibr ...
-
Saber, Wael
-
Barrett, John
-
Hermine, Olivier
-
Hägglund, Hans
-
Sperr, Wolfgang ...
-
Popat, Uday
-
Alyea, Edwin P
-
Devine, Steven
-
Deeg, H Joachim
-
Weisdorf, Daniel
-
Akin, Cem
-
Valent, Peter
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Hematology
- Articles in the publication
-
Journal of Clini ...
- By the university
-
Uppsala University
-
Karolinska Institutet